Literature DB >> 29902065

Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.

Zhe Wu1,2, Jiang Tan1,2, Yujing Chi3, Feng Zhang1,2, Jun Xu1,2, Yang Song1,2, Xu Cong4, Na Wu3, Yulan Liu1,2.   

Abstract

Visceral adipose tissue (VAT) is related to nonalcoholic fatty liver disease (NAFLD). However, the role of mesenteric adipose tissue (MAT), part of the VAT, in NAFLD is unclear. In the present study, we monitored the liver and four depots of the VAT in high-fat diet (HFD)-feeding mice at multiple time points (4, 8, and 12 wk). The MAT had become inflamed by the eighth week of HFD feeding, earlier than other depots of VAT. Furthermore, MAT removal after 8 wk of HFD resulted in more severe steatosis and more foci of inflammation infiltration, as well as higher NAFLD activity scores. Consistent with these findings, the mRNA expression of proinflammatory cytokines and lipid anabolism genes was increased in the livers of inflamed MAT-removal mice. MAT removal also injured the intestinal barrier and promoted intestinal inflammation. The bacterial load translocated to the liver and circulating levels of lipopolysaccharide were also evaluated in inflamed MAT-removal mice. In a coculture experiment involving adipocytes and intestinal epithelial cells, mRNA expression of zonula occludens-1 (ZO-1), and occludin in CT-26 cells was upregulated and permeability of monolayer Caco-2 cells was elevated under stimulation from adipocytes or inflamed adipocytes. Taken together, these results demonstrated that MAT removal damaged the intestinal barrier and aggravated NAFLD and that MAT inflammation may be a compensatory response to protect the liver by maintaining the intestinal barrier. NEW & NOTEWORTHY The mesenteric adipose tissue (MAT) lies between the gut and liver and plays a critical role in hepatic metabolic diseases. In the present study, we found that the MAT was prone to inflammation in high-fat diet-fed mice. Removal of the inflamed MAT resulted in more hepatic inflammation, lipid accumulation, and decreased glucose tolerance. Furthermore, we showed that the MAT contributed to intestinal barrier integrity, thus clarifying why MAT removal aggravated nonalcoholic fatty liver disease.

Entities:  

Keywords:  bacterial translocation; intestinal barrier; mesenteric adipose tissue; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2018        PMID: 29902065     DOI: 10.1152/ajpgi.00079.2018

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

1.  Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance.

Authors:  Darcy E Kahn; Bryan C Bergman
Journal:  Diabetes       Date:  2022-04-01       Impact factor: 9.461

Review 2.  Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.

Authors:  Maria Petrescu; Sonia Irina Vlaicu; Lorena Ciumărnean; Mircea Vasile Milaciu; Codruța Mărginean; Mira Florea; Ștefan Cristian Vesa; Monica Popa
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

3.  Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane.

Authors:  F S Lemos; J X Pereira; V F Carvalho; E S Bernardes; R Chammas; T M Pereira; R S Carvalho; R Luisetto; M C El-Cheikh; S Calil-Elias; F L Oliveira
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

4.  E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization.

Authors:  Yifan Zhang; Weiwei Jiang; Jun Xu; Na Wu; Yang Wang; Tianyu Lin; Yun Liu; Yulan Liu
Journal:  Front Cell Infect Microbiol       Date:  2020-12-11       Impact factor: 5.293

5.  Screening for anti-adipogenic, pro-lipolytic and thermogenic plant extracts by models associating intestinal epithelial cells with human adipose cells.

Authors:  Damien Guillemet; Chloé Belles; Aurélie Gomes; Vincent Azalbert; Mathilde André; Nourdine Faresse; Rémy Burcelin; Jean-Michel Lagarde; Danièle Lacasa; Mayoura Kéophiphath
Journal:  Eur J Nutr       Date:  2022-01-29       Impact factor: 4.865

Review 6.  Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options.

Authors:  Agata Twardowska; Adam Makaro; Agata Binienda; Jakub Fichna; Maciej Salaga
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.